TY - JOUR
T1 - Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community
AU - Esquivel, Jesus
PY - 2007/7/1
Y1 - 2007/7/1
N2 - Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) continue to play an increasing role in the management of peritoneal surface malignancies of gastrointestinal origin. The prognosis of patients and the responses to cytoreductive surgery and HIPEC depend on the histology, the degree of malignant transformation, the adequacy of the cytoreductive surgery, and the response to systemic therapy. Continuous interaction between medical and surgical oncologists is needed to identify the most appropriate patients for and the most efficient sequence of the available therapeutic modalities.
AB - Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) continue to play an increasing role in the management of peritoneal surface malignancies of gastrointestinal origin. The prognosis of patients and the responses to cytoreductive surgery and HIPEC depend on the histology, the degree of malignant transformation, the adequacy of the cytoreductive surgery, and the response to systemic therapy. Continuous interaction between medical and surgical oncologists is needed to identify the most appropriate patients for and the most efficient sequence of the available therapeutic modalities.
UR - http://www.scopus.com/inward/record.url?scp=34250825507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250825507&partnerID=8YFLogxK
U2 - 10.1016/j.soc.2007.04.015
DO - 10.1016/j.soc.2007.04.015
M3 - Review article
C2 - 17606199
AN - SCOPUS:34250825507
SN - 1055-3207
VL - 16
SP - 653
EP - 666
JO - Surgical Oncology Clinics of North America
JF - Surgical Oncology Clinics of North America
IS - 3
ER -